BioCardia, Inc. (BCDA)
0.921
-0.01
(-0.83%)
USD |
NASDAQ |
Oct 23, 16:00
0.9225
0.00 (0.00%)
After-Hours: 20:00
BioCardia Price to Book Value : 5.111 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.111 |
| October 22, 2026 | 5.154 |
| October 21, 2026 | 5.452 |
| October 20, 2026 | 5.772 |
| October 19, 2026 | 4.981 |
| October 16, 2026 | 5.106 |
| October 15, 2026 | 5.208 |
| October 14, 2026 | 5.146 |
| October 13, 2026 | 5.496 |
| October 12, 2026 | 5.661 |
| October 09, 2026 | 5.772 |
| October 08, 2026 | 5.883 |
| October 07, 2026 | 6.049 |
| October 06, 2026 | 5.883 |
| October 05, 2026 | 6.049 |
| October 02, 2026 | 5.772 |
| October 01, 2026 | 5.661 |
| September 30, 2026 | 5.605 |
| September 29, 2026 | 5.716 |
| September 28, 2026 | 5.772 |
| September 25, 2026 | 5.827 |
| September 24, 2026 | 5.938 |
| September 23, 2026 | 5.827 |
| September 22, 2026 | 5.827 |
| September 21, 2026 | 5.994 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.493 |
| September 17, 2026 | 6.160 |
| September 16, 2026 | 6.937 |
| September 15, 2026 | 6.826 |
| September 14, 2026 | 6.604 |
| September 11, 2026 | 5.994 |
| September 10, 2026 | 6.105 |
| September 09, 2026 | 6.105 |
| September 08, 2026 | 6.160 |
| September 04, 2026 | 5.994 |
| September 03, 2026 | 6.049 |
| September 02, 2026 | 6.160 |
| September 01, 2026 | 6.105 |
| August 31, 2026 | 6.327 |
| August 28, 2026 | 6.382 |
| August 27, 2026 | 6.493 |
| August 26, 2026 | 6.604 |
| August 25, 2026 | 6.271 |
| August 24, 2026 | 5.883 |
| August 21, 2026 | 5.605 |
| August 20, 2026 | 5.367 |
| August 19, 2026 | 5.500 |
| August 18, 2026 | 5.413 |
| August 17, 2026 | 5.217 |
| August 14, 2026 | 5.404 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cytokinetics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
Price to Book Value Related Metrics
| Price | 0.921 |
| Earnings Yield | -82.84% |
| Market Cap | 13.80M |